Granulomatosis with polyangiitis

From WikiLectures

Granulomatosis with polyangiitis (formerly Wegener's granulomatosis[1]) is a necrotizing vasculitis of small vessels that affects:

Clinical picture[edit | edit source]

General symptoms
febrile, weight loss, fatigue;
ORL area
inflammation (up to necrotizing) of the upper respiratory tract with the formation of ulcers, epistaxis, sinusitis, destruction of the nasal cartilages with the formation of the so-called saddle nose, subglottic stenosis of the trachea manifested by stridor with danger of acute asphyxia, chronic carrier of Staphylococus aureus;
otitis media, conductive hearing disorders;
Lower respiratory tract
cough, chest pain, hemoptysis from typical necrotizing granulomas in the bronchi;
Kidney
rapidly progressing glomerulonephritis (ANCA-positive glomerulonephritis) with an acutely developing picture renal insufficiency;

Gastrointestinal tract: diarrhoea, enterorrhagia, abdominal pain, endoscopically demonstrable haemorrhages and ulcerations;

Peripheral nerves
mononeuritis multiplex;
Eyes
inflammation of the cornea with the formation of ulcers, danger of blindness;

Locomotor system: arthralgia, myalgia, erosive arthritis.

Diagnostics[edit | edit source]

Glomerulonephritis in an ANCA positive patient.
Arthritis-granulomatous inflammation and necrosis in a patient with Wegener's granulomatosis

Laboratory findings:

  • PAF, ↑ FW, hypergammaglobulinemia;
  • anemia, leukocytosis, thrombocytopenia;
  • proteinuria, erythrocyturia
  • c-ANCA antibodies (positivity recedes as disease activity subsides);
  • rheumatoid factors are demonstrated in some patients;
  • granulomatous inflammation' in a biopsy specimen.

X-ray of lungs:

  • Butterfly shading or nodal shading.
Renal biopsy
  • Focal to focal-segmental glomerulonephritis;
  • histologically, sometimes demonstrable vasculitis of small vessels.

Therapy[edit | edit source]

Prognosis[edit | edit source]

  • Depends on the degree of kidney involvement, 90% of patients survive an average of five years;
  • untreated disease has a poor prognosis: up to 70% of patients die;
  • has a tendency to "relapses", they are frequent, they appear in up to 50% of patients even several years after diagnosis, often in connection with infection or reduction of corticosteroid doses, large relapses are treated with pulsed application of methylprednisone and cyclophosphamide, minor relapses by increasing the maintenance dose.


Links[edit | edit source]

Related Articles[edit | edit source]

References[edit | edit source]

  • KLENER, P, et al. Vnitřní lékařství. 3. edition. Praha : Galén, 2006. ISBN 80-7262-430-X.


References[edit | edit source]

Missing link to the original WikiScripta article